Safety and Efficacy of Percutaneous Autogenous Arteriovenous Fistula Creation
Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis
Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions
Bicarbonate vs. Saline for Prevention of Contrast Nephropathy
Outcomes of Transapical vs. Transfemoral TAVR Outcomes
CHAMPION PHOENIX IPST
Implications of Intraprocedural Stent Thrombosis During PCI
Hydrophilic Na+/H+ Exchanger Inhibitor in STEMI
TAVR With a Repositionable Self-Expanding Transcatheter Heart Valve in Severe Aortic Stenosis
Renal Denervation in Patients With Resistant Hypertension
Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents
Paclitaxel-Eluting Stents vs. CABG in Triple Vessel and Left Main CAD
Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Hypertensive Patients
BioMatrix Stent Better Over Longer Term
SAN FRANCISCO — In patients with ST-segment elevation myocardial infarction, the benefits of the biolimus-eluting BioMatrix stent over a bare-metal stent were sustained through 2 years, a randomized trial showed.
Are Dissolving Scaffolds a True Advance?
SAN FRANCISCO — Hopes are high for bioresorbable scaffolds as alternatives to drug-eluting stents, but without much data comparing the two the outlook for the newer devices remains uncertain.